Elkhorn S&P MidCap Financials Portfolio XF 深 滬
等待開盤 10-03 09:30:00 美东时间
14.38
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 14.38
- 總市值 0
- 52周最高 16.554
- 市盈率 靜 --
- 換手率 NaN.00%
- 52周最低 14.332
- 委 比 0.00%
- 總股本 --
- 歷史最高 16.554
- 量 比 0
- 振 幅 0.00%
- 歷史最低 14.332
- 每 手 1
- 風險率
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多中国高管主导的SPAC XFLH Capital(XFLHU.US)申请美股IPO 拟筹资6000万美元
由中国高管主导的特殊目的收购公司（SPAC）XFLH Capital于周一向美国证券交易委员会（SEC）提交文件，申请通过首次公开发行股票（IPO）募资至多6000万美元。
09-30 15:43
500亿估值独角兽IPO，京东的野心藏不住了
来源：财经早餐 9月23日消息，中国证监会近日发布关于JINGDONG Industrials，Inc．（即京东工业）境外发行上市备案通知书。京东工业拟...
09-25 07:18
Impex Ferro Tech Limited Undergoes Corporate Insolvency Resolution Process
Impex Ferro Tech Ltd ( ($IN:IMPEXFERRO) ) has provided an announcement. Impex F...
09-20 18:58
Gary Black Says Tesla Stock Will Go 'Higher' — Predicts Decline In Q4: 'We Expect TSLA...'
Gary Black predicts Tesla stock will rise in Q3 before falling in Q4 amid rally fueled Elon Musk's recent stock purchase.
09-19 13:43
Moderna Stock Is Moving Higher Tuesday: Here's Why
Moderna, Inc. (NASDAQ:MRNA) shares are up nearly 5% on Tuesday after the company announced positive preliminary immunogenicity data for its 2025-2026 Spikevax formula, which targets the new LP.8.1 variant of COVID-19.
09-17 03:41
Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax
Moderna's updated Spikevax shows strong antibody response and safety, targeting dominant COVID-19 variants like LP.8.1 in high-risk and older adults.
09-16 22:49
Recessed door handles raise safety concerns across automakers - report
Tesla’s (NASDAQ:TSLA) recessed door handles are raising safety concerns among customers and regulators in the wake of several fatal – and near fatal – accidents that have prevented drivers and passeng...
09-11 01:18
ABL Group ASA Announces Insider Share Transactions
An update from AqualisBraemar ASA ( ($GB:0QXF) ) is now available. ABL Group AS...
09-09 22:03
Tevogen Highlights Clinical Data For TVGN 489, A T Cell Therapy Targeting COVID-19 In Immunocompromised Patients
Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN), today highlighted the continuing need for SARS-CoV-2 treatments for individuals with weakened immune systems, who are at the highest risk of complications
09-04 04:17
